President Trump’s August 31 Oval Office announcement on healthcare affordability centers on codifying Most-Favored-Nation drug pricing agreements, expanding the TrumpRx platform, and redirecting Affordable Care Act subsidies directly to enrollees rather than insurers. Recent White House data showed the steepest annual prescription drug price decline since 1963, with MFN deals covering 86% of the branded market and generating hundreds of millions in patient savings through TrumpRx. The event follows January’s rollout of the Great Healthcare Plan and August updates on price transparency amid rising premiums after expanded subsidies expired. Traders price specific phrases based on Trump’s prior emphasis on holding insurers accountable, criticizing pharmacy benefit managers, and highlighting international price comparisons, while monitoring any mentions of particular manufacturers or policy mechanics that could influence congressional action.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedR&D / Research and Development
100%
Neurocrine
3%
Failing Nation / Failing Country
49%
Protester
-
Madrigal
16%
Psychiatric / Psychedelic
11%
London
99%
Middleman / Middle Man
-
Rare / Chronic
100%
Obama
50%
Kharg / Island
50%
Minesweeper / Mine Dropper
-
AI / Artificial Intelligence
54%
Venezuela
100%
Mental / Mentally
-
-No Qualifying Event-
<1%
$7,083 Vol.
R&D / Research and Development
100%
Neurocrine
3%
Failing Nation / Failing Country
49%
Protester
-
Madrigal
16%
Psychiatric / Psychedelic
11%
London
99%
Middleman / Middle Man
-
Rare / Chronic
100%
Obama
50%
Kharg / Island
50%
Minesweeper / Mine Dropper
-
AI / Artificial Intelligence
54%
Venezuela
100%
Mental / Mentally
-
-No Qualifying Event-
<1%
This market will resolve to "Yes" if Donald Trump says the listed term during the specified appearance. Otherwise, the market will resolve to "No".
This market is explicitly about Trump's announcement on healthcare affordability in the Oval Office on August 31, 2026 (https://rollcall.com/factbase/trump/calendar/). Speeches, events, or comments that occur outside of the named, scheduled event will not qualify toward this market's resolution.
If this event is definitively cancelled, or otherwise is not available by September 1, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio/video of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Mentions/Event+Mentions+Contract+DeFi.pdf
Market Opened: Aug 31, 2026, 11:03 AM ET
Resolver
0x65070BE91...This market will resolve to "Yes" if Donald Trump says the listed term during the specified appearance. Otherwise, the market will resolve to "No".
This market is explicitly about Trump's announcement on healthcare affordability in the Oval Office on August 31, 2026 (https://rollcall.com/factbase/trump/calendar/). Speeches, events, or comments that occur outside of the named, scheduled event will not qualify toward this market's resolution.
If this event is definitively cancelled, or otherwise is not available by September 1, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No".
The resolution source will be audio/video of the event.
For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Mentions/Event+Mentions+Contract+DeFi.pdf
Resolver
0x65070BE91...President Trump’s August 31 Oval Office announcement on healthcare affordability centers on codifying Most-Favored-Nation drug pricing agreements, expanding the TrumpRx platform, and redirecting Affordable Care Act subsidies directly to enrollees rather than insurers. Recent White House data showed the steepest annual prescription drug price decline since 1963, with MFN deals covering 86% of the branded market and generating hundreds of millions in patient savings through TrumpRx. The event follows January’s rollout of the Great Healthcare Plan and August updates on price transparency amid rising premiums after expanded subsidies expired. Traders price specific phrases based on Trump’s prior emphasis on holding insurers accountable, criticizing pharmacy benefit managers, and highlighting international price comparisons, while monitoring any mentions of particular manufacturers or policy mechanics that could influence congressional action.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions